Immatics NV (IMTX)
7.59
-0.85
(-10.07%)
USD |
NASDAQ |
Oct 02, 16:00
7.60
+0.01
(+0.13%)
After-Hours: 20:00
Immatics EPS Diluted (Quarterly) : -0.5316 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5316 |
| March 31, 2026 | -0.5023 |
| December 31, 2025 | -0.3296 |
| September 30, 2025 | -0.4859 |
| June 30, 2025 | -0.656 |
| March 31, 2025 | -0.3451 |
| December 31, 2024 | 0.3937 |
| September 30, 2024 | -0.0565 |
| June 30, 2024 | -0.1879 |
| March 31, 2024 | -0.0246 |
| December 31, 2023 | -0.3322 |
| September 30, 2023 | -0.3456 |
| June 30, 2023 | -0.3464 |
| March 31, 2023 | -0.2763 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.2292 |
| Date | Value |
|---|---|
| March 31, 2022 | 1.516 |
| December 31, 2021 | -0.3049 |
| September 30, 2021 | -0.5097 |
| June 30, 2021 | -0.5081 |
| March 31, 2021 | -0.4368 |
| December 31, 2020 | -0.0912 |
| September 30, 2020 | -3.044 |
| June 30, 2020 | -0.3684 |
| March 31, 2020 | -0.1455 |
| December 31, 2019 | -0.2589 |
| September 30, 2019 | -0.0833 |
| June 30, 2019 | -0.1154 |
| March 31, 2019 | -0.1026 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MediGene AG | -- |
| InflaRx NV | -0.1052 |
| BioNTech SE | -3.799 |
| Twist Bioscience Corp. | -0.5617 |
| Prime Medicine, Inc. | -0.2376 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -72.66M |
| Revenue (Quarterly) | 10.63M |
| Total Expenses (Quarterly) | 83.29M |
| Enterprise Value | 604.46M |
| Profit Margin (Quarterly) | -683.4% |
| Earnings Yield | -24.37% |
| Normalized Earnings Yield | -24.38 |